Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Decitabine and Cytarabine for Older Newly Diagnosed AML
NCT01829503Phase 2Completed
- Start
- Feb 2013
- Primary completion
- Oct 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of decitabine, cytarabine in acute myeloid leukemia (AML). Started Feb 2013; status: completed.
02
Drugs
decitabinecytarabine
03
Conditions
acute myeloid leukemia (AML)
Beyond the preview
Go deeper on NCT01829503.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01829503.